ID

37648

Beskrivning

Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer

Nyckelord

Versioner (1)
  1. 2019-08-13 2019-08-13 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

13 augusti 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612

Engelsk

Cycle 7

1 Formulär  
  1. StudyEvent: ODM
    1. Cycle 7
Administrative Data
Beskrivning

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Number
Beskrivning

Patient number

Datatyp

integer

Alias
UMLS CUI [1]
C1830427
Day 1-5
Beskrivning

Day 1-5

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C0449438
Has the cycle been delayed?
Beskrivning

Clinical Trials, Delay of chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
If Yes, please document the reason
Beskrivning

Clinical Trials, Delay of chemotherapy, Reason and justification

Datatyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Please specify
Beskrivning

Clinical Trials, Delay of chemotherapy, Reason and justification

Datatyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Administration of study medication topotecan (oral)
Beskrivning

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Day
Beskrivning

Experimental drug, Topotecan, Administration of medication, Day

Datatyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0439228
Date
Beskrivning

Experimental drug, Topotecan, Administration of medication, Date in time

Datatyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0011008
Planned daily dose for this cycle
Beskrivning

Experimental drug, Topotecan, Daily Dose, Planned

Datatyp

text

Måttenheter
  • mg/m2
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C2348070
UMLS CUI [1,4]
C1301732
Administered dose for this cycle
Beskrivning

Experimental drug, Topotecan, Dosage

Datatyp

integer

Måttenheter
  • mg
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0178602
mg
Administration of study medication topotecan (oral)
Beskrivning

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Capsules dispensed on
Beskrivning

Experimental drug, Topotecan, Dispense, Date in time

Datatyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1880359
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beskrivning

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datatyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of 0,25 mg capsules
Beskrivning

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datatyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Capsules returned by the patient on
Beskrivning

Experimental drug, Topotecan, Returned, Date in time

Datatyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0332156
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beskrivning

Experimental drug, Topotecan, Capsule, Returned Amount

Datatyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Number of 0,25 mg capsules
Beskrivning

Experimental drug, Topotecan, Capsule, Returned Amount

Datatyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Has the dose been modified when compared to the previous cycle?
Beskrivning

Experimental drug, Topotecan, Medication dose changed

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
If "yes", please document the reason
Beskrivning

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datatyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Please specify
Beskrivning

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datatyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Tillbaka till toppen

Similar models

Cycle 7

1 Formulär
  1. StudyEvent: ODM
    1. Cycle 7
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Day 1-5
C0008976 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Clinical Trials, Delay of chemotherapy
Item
Has the cycle been delayed?
boolean
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
Item
If Yes, please document the reason
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
If Yes, please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Item
Please specify
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
Please specify
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Item
Day
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,4])
Experimental drug, Topotecan, Administration of medication, Day
Code List
Day
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Experimental drug, Topotecan, Administration of medication, Date in time
Item
Date
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
Planned daily dose for this cycle
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C1301732 (UMLS CUI [1,4])
Laboratory Procedures, Hematology finding, Visit
Code List
Planned daily dose for this cycle
CL Item
Baseline (1)
CL Item
Day 1 (2)
CL Item
Day 8 (3)
CL Item
Day 15 (4)
Experimental drug, Topotecan, Dosage
Item
Administered dose for this cycle
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Experimental drug, Topotecan, Dispense, Date in time
Item
Capsules dispensed on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Returned, Date in time
Item
Capsules returned by the patient on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed
Item
Has the dose been modified when compared to the previous cycle?
boolean
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
Item
If "yes", please document the reason
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Code List
If "yes", please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Item
Please specify
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial